LMATLeMaitre Vascular, Inc.
Is it safe?
Strong, no red flags: a safe balance sheet and clean books.
Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).
Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.
Moderate price swings, typical volatility. Worst drawdown -48% · now 31% below its 52-week high.
Unless marked, from SEC EDGAR, as of Dec 31, 2025.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can LMAT take a bad year?
The deepest fall in LMAT's price history on file is −48%; it is 31% below its high today.
Altman Z-score · distress below 1.8 · safe above 3 · safe zone, the balance sheet is not what threatens this one
- Interest cover
- 14.9×
Interest cover · operating profit covers the interest bill several times over
- Annualised volatility
- 41%
Annualised volatility · roughly twice as jumpy as the market
- Worst drawdown on file
- −48%
Worst drawdown on file · −31% today
Details›
- Cash and short-term investments
- $376M
- EBITDA, trailing twelve months
- $85M
- Operating profit, trailing twelve months
- $77M
- Annualised volatilitytwo years of daily moves
- 41%
- Worst drawdown on file
- −48%
- Below its 52-week high
- 31%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Instruments & Supplies
Ranks #2 of 21 by RyuScore